"Taking Science Personally," a feature story leading a special section on "Giving" in The New York Times, captures the challenges of speeding drug development for a complex disease — as well as how MJFF is working to tackle them.
11/11/2008 Team Fox Marathon Special to Air on The Rachael Ray Show, Wednesday, November 12!
Tune into The Rachael Ray Show on Wednesday, November 12, for a Team Fox Marathon special featuring Team Fox Celebrity Chair Ryan Reynolds, 40 of our 130 ING NYC Marathon runners and a surprise visit from Michael J. Fox.
11/07/2008 MJFF grant application system will be unavailable weekend of November 14-16
Due to work on the external server that processes online applications to The Michael J. Fox Foundation, our online grant application system will be unavailable from 8 p.m. Friday, November 14, to 8 p.m. Sunday, November 16 (all times U.S. ET).
11/06/2008 With Performance by The Who, MJFF Raises $4.3 Million at 2008 ‘Funny Thing’
The Michael J. Fox Foundation raised an incredible $4.3 million for Parkinson’s research at its gala event, “A Funny Thing Happened on the Way to Cure Parkinson’s,” held Wednesday, November 5, at the Sheraton New York.
11/03/2008 Michael J. Fox Foundation Names Core Programs in Honor of Humanitarian Edmond J. Safra
MJFF’s Edmond J. Safra Core Programs for PD Research are three annual funding initiatives designed to keep the drug development pipeline for Parkinson’s disease flowing with novel, high-impact ideas promising tangible improvements in patients’ quality of life sooner rather than later.
The Michael J. Fox Foundation today announced the availability of up to $11 million in 2009 funding for research toward transformative treatments and a cure for Parkinson’s disease.
Actor Ryan Reynolds, celebrity chair of Team Fox, completed The 2008 ING NYC Marathon -- his first -- in under four hours, raising over $80,000 for Parkinson's research and inspiring countless friends and fans the world over.
10/14/2008 Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinson's Disease
The Michael J. Fox Foundation for Parkinson’s Research awarded a total of $2 million to five research teams to speed development of effective therapies for the under-addressed cognitive and mood-related symptoms of Parkinson’s disease.
10/13/2008 Big-name Investors Bravely Give Picks at Dallas Seminar
The second annual Great Investors' Best Ideas Foundation Investment Symposium, held last week in Dallas, raised more than $1 million, half of which will benefit The Michael J. Fox Foundation for Parkinson's Research.
The Michael J. Fox Foundation has announced the Team Fox Challenge, a program to inspire increased participation in Team Fox, MJFF’s national grassroots community fundraising program.
09/24/2008 Read Katie Hood's Blog on The Huffington Post: The Patient Empowerment Revolution
In the wake of Google co-founder Sergey Brin's disclosure that he carries a genetic mutation increasing his risk for Parkinson's disease, Katie Hood blogs on the potential of genetic research to empower all of us to take ownership of our medical futures.
09/24/2008 Katie Hood Appointed to NINDS Council
Katie Hood, chief executive officer of The Michael J. Fox Foundation for Parkinson’s Research, is one of four new members appointed to the NINDS Council, the major advisory panel to The National Institute of Neurological Disorders and Stroke (NINDS). She will serve through July 2012.
09/24/2008 Reminder: Contributions to MJFF Support Parkinson's Research, Not Political Candidates or Campaigns
Contributions made to The Michael J. Fox Foundation for Parkinson's Research support our organization's research efforts and are not used to support any political candidate or campaign.
09/17/2008 Save the Date: Research Roundtable in Chicago on October 21
The Michael J. Fox Foundation invites you to attend a Research Roundtable presentation titled "The MJFF Funding Philosophy and Research Portfolio Highlights."
The Michael J. Fox Foundation announced today that actor Ryan Reynolds will serve as the first Celebrity Chair of Team Fox, the Foundation’s grassroots fundraising initiative.
The Michael J. Fox Foundation today announced that it would award Santa Monica-based biotech ArmaGen Technologies, Inc., up to $1 million if all milestones are met to take practical steps toward developing a “Trojan horse” delivery technology for the treatment of Parkinson’s disease.
08/06/2008 MEDIA ALERT: Michael J. Fox Foundation to Host PD Therapeutics Conference September 15 in Chicago
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) will host its second annual PD Therapeutics Conference on Monday, September 15, in Chicago.
MJFF funded 15 high-risk, high-reward Parkinson’s disease research projects under Rapid Response in the first half of the year. Applications are still being accepted, and a total of $2 million in Rapid Response awards is expected by year’s end.
Latest awards under Therapeutics Development Initiative bring MJFF’s current active industry collaborations to 23; next industry-only deadline January 20, 2009
The Michael J. Fox Foundation for Parkinson’s Research today announced approximately $2.4 million in total funding to nine research teams under its Target Validation initiative.
06/26/2008 Read Katie Hood's Blog on The Huffington Post
Just back from speaking at the 2008 BIO Global Convention, MJFF CEO Katie Hood continued her Huffington Post blog with thoughts on how strategic partnerships betwewn nonprofits and industry can help speed the development of cures for Parkinson's and other diseases.
06/26/2008 LPGA Golfer Jane Park to Raise Funds for Michael J. Fox Foundation for Parkinson's Research
Golf pro Jane Park, playing in the U.S. Women's Open, will donate a portion of her earnings to The Michael J. Fox Foundation to help fund critically needed Parkinson’s research.
06/03/2008 Michael J. Fox Foundation Commits Up to $2 Million to Visualize Alpha-Synuclein Protein in the Brain
Funding to be issued under second round of Critical Challenges in Parkinson’s Disease initiative
05/12/2008 Michael J. Fox Foundation "Plays to Win" at Third L.A. Fundraiser
In an exclusive two-part interview, Michael J. Fox talked to "Access Hollywood" about Parkinson's disease, the Foundation's progress, and his excitement to be back in Los Angeles surrounded by friends supporting the Foundation at "Playing to Win the Fight against Parkinson's," a poker tournament benefit held at Social Hollywood.
04/28/2008 14th Annual Parkinson's Unity Walk Raises Funds, Awareness for Parkinson's Research
The 14th annual Parkinson's Unity Walk, held in New York City's Central Park on Saturday, April 26, 2008, brought together over 10,000 members of the Parkinson's community to raise funds and awareness for Parkinson's research.
04/28/2008 'Agitation and Idealism' -- Read Katie Hood's Comments from the 14th Annual Parkinson's Unity Walk
Read a transcript of remarks given by Katie Hood, MJFF CEO, at the 14th Annual Parkinson's Unity Walk held in New York City's Central Park on Saturday, April 26, 2008.
04/24/2008 Four Questions For: Marlene Kahan, Executive Director, ASME
Mediabistro.com's FishbowlNY blog spoke with Marlene Kahan, PWP and executive director of the American Society of Magazine Editors (ASME), about the sense of purpose she feels raising awareness of Parkinson's, and whether she thinks the magazine industry does enough for staffers battling diseases like hers.
The Michael J. Fox Foundation announced a $5.6-million award to drive a Phase 2 clinical trial to investigate the potential of inosine — a naturally occurring chemical that gives rise to urate in the body — to slow or stop the progression of Parkinson’s disease.
04/07/2008 Registration Open for Annual PD Therapeutics Conference
The Michael J. Fox Foundation has opened registration for its annual PD Therapeutics Conference to be held in Chicago, Illinois, on September 15, 2008.
The Michael J. Fox Foundation for Parkinson’s Research seeks applications for its $10-million 2008 Therapeutics Development Initiative. The 2008 program includes a special funding track for academic researchers.
03/25/2008 Michael J. Fox Foundation Commits Up to $2 Million to Improve Drug Delivery for Parkinson's Disease
The Michael J. Fox Foundation for Parkinson’s Research announced the launch of a new funding program, Improving Delivery of Parkinson’s Disease Therapeutics to the Brain.
The Foundation has announced a $1-million new Web-based Clinical Assessment Program to drive the creation and testing of Web-based tools that would allow any patient with a personal computer and an Internet connection to participate in clinical research from the comfort of their own home.
The Michael J. Fox Foundation for Parkinson’s Research would like to bring to your attention the following meeting: 2008 AAPS Workshop on Demonstrating Disease Modifying Effects for the Treatment of Parkinson’s Disease: Drug Development and Regulatory Issues.
Michael J. Fox Foundation for Parkinson’s Research today announced the 2008 launch of its annual Clinical Intervention Awards.
02/13/2008 Save the Date: Research Roundtable in Ft. Lauderdale, Florida, on March 25
The Michael J. Fox Foundation invites you to attend a Research Roundtable presentation titled "The MJFF Funding Philosophy and Research Portfolio Highlights."
Four industry research projects targeted as part of innovative Therapeutics Development Initiative.
Approximately $2 million in total funding was awarded to seven research studies aiming to advance the ability of the Parkinson’s research field, and drug makers, to therapeutically target two genes — LRRK2 and alpha-synuclein.
Founding gift for “The Grove Circle,” honoring planned gift donors,
reflects shared commitment to transformative approach
01/10/2008 Save the Date: Research Roundtable in Menlo Park, California, on January 15
The Michael J. Fox Foundation invites you to attend a Research Roundtable presentation titled "MJFF Strategic Overview: The Michael J. Fox Foundation's Philosophy and Role in Funding Translational Research for Parkinson's Therapies."
A research team funded under the Foundation's LEAPS (Linked Efforts to Accelerate Parkinson's Solutions) initiative will work to optimize a small interfering RNA (siRNA)-based therapeutic that could slow or stop the progression of Parkinson’s disease by reducing expression of the protein alpha-synuclein.
